Fig. 2From: Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastasesGTV mean dose (a), D98% (b), D2% (c), and heterogeneity index (d) versus effective PTV diameter for the 80% and the SIB conceptBack to article page